8-Bromo-3-Methylxanthine CAS 93703-24-3 Linagliptin Entèmedyè Pite ≥99.0% Faktori
Manifakti bay Linagliptin ak entèmedyè ki gen rapò:
Linagliptin CAS 668270-12-0
Linagliptin Parent Nucleus Intermediate CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl) -3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidin CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Non Chimik | 8-Bromo-3-Methylxanthine |
Sinonim | 8-Bromo-3-Methyl-3,7-dihydro-1H-purine-2,6-dyon |
Nimewo CAS | 93703-24-3 |
Nimewo CAT | RF-PI501 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C6H5BrN4O2 |
Pwa molekilè | 245.03 |
Pwen k ap fonn | 300℃ (lit.) |
Dansite | 1.974g/cm3 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan ak jòn limyè |
Pite | ≥99.0% |
Pèt sou siye | ≤0.50% |
Rezid sou ignisyon | ≤0.50% |
Single enpurte | ≤0.50% |
Enpurte total | ≤1.0% |
Metal lou | ≤20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè pou Linagliptin (CAS: 668270-12-0) |
Pake: Boutèy, sache papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite.
8-Bromo-3-Methylxanthine (CAS: 93703-24-3) se yon derive ranplase Xanthine.Li ka itilize pou sentèz Linagliptin (CAS: 668270-12-0), ki se yon nouvo inibitè ki pisan ak selektif dipeptidyl peptidase-4 (DPP-4) ak itilizasyon potansyèl nan tretman dyabèt tip 2.Li te apwouve pa US FDA nan mwa me 2011 pou tretman dyabèt tip 2 ansanm ak rejim alimantè ak fè egzèsis.Originator se Boehringer Ingelheim (Etazini).